Adam de Havenon, MD, MSCI

My main areas of research include: 1) intracranial atherosclerosis, 2) white matter hyperintensities and VCID, and 3) blood pressure variability.

During vascular neurology fellowship training, I discovered that I want the expertise to successfully fill the space between the basic science of stroke research and its implementation in human subjects. My long-term research goal is to bridge these fields and lead a team of basic and clinical researchers to address the most treatment-resistant diseases in vascular neurology and to provide excellent care to patients suffering from these diseases. I have consistently obtained competitive grant awards, including a K23, R01, and UG3/UH3 from NIH/NINDS. In 2021, I finished a Masters of Science in Clinical Investigation degree. I am the principal investigator of the observational trial in my K23, the multicenter BP-VISO study, and the StrokeNet study CAPTIVA-MRI. At my prior institution, I established the de Havenon Lab and mentees in my lab received a number of research awards and scholarships, including an NIH NRS training grant and an American Academy of Neurology Medical Student Research Scholarship. In 2022, we established the de Havenon lab at Yale and have been expanding its footprint. The lab's goal is to advance research that will benefit patients with stroke and to help train the next generation of cerebrovascular researchers.